Roadman Investments Corp. announced that, in connection with Roadman's recent acquisition of CLOV Biopharma Corp. ("CBP"), Dr. James Hudson, Ph.D has been appointed to the company's Scientific Advisory Board effective immediately. Dr. James B. Hudson, Ph.D, Professor Emeritus Department of Pathology &Laboratory Medicine at the University of British Columbia. Dr. Hudson will assist CBP and Roadman with further studies to research the effectiveness of cedar leaf oil vapour ("CLOV") on the Coronavirus.